MAPT and Alzheimer disease: Alzheimer’s disease (AD) results in cognitive decline and brain atrophy that is characterised by multiple pathologies, including the formation of abnormal extracellular protein deposits of β-amyloid (Aβ), intracellular tangles of tau, alongside neuroinflammation and the loss of neurons and synapses1.